TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Controlled Clinical Trial of Two Different Oral Care Regimens Combined With Ventilator-Associated Pneumonia (VAP) Bundle Strategy for Reduction of Duration of Mechanical Ventilation in a Neonatal Population
Brief Summary: The goal of this pilot study is to test the hypothesis that mechanically ventilated infants receiving Biotene OralBalance® gel for oral care would have a reduced intubation time compared to infants receiving oral care placebo. This study is also performed to test the feasibility as well the safety of Biotene OralBalance® gel.


Options:
A: Arm Label: Biotene OralBalance® gel Arm; Type: EXPERIMENTAL; Interventions: Drug: Biotene OralBalance® gel | Arm Label: Sterile Water Arm; Type: PLACEBO_COMPARATOR; Interventions: Other: Sterile Water moisten cotton tipped applicator | Intervention Type: DRUG; Name: Biotene OralBalance® gel; Assigned to Arm(s): Biotene OralBalance® gel Arm | Intervention Type: OTHER; Name: Sterile Water moisten cotton tipped applicator; Assigned to Arm(s): Sterile Water Arm
B: Arm Label: povidone iodine; Type: EXPERIMENTAL; Interventions: Drug: povidone iodine | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: povidone iodine; Assigned to Arm(s): povidone iodine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): placebo
C: Arm Label: 1; Type: PLACEBO_COMPARATOR; Interventions: Other: placebo | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Other: oral hygiene | Intervention Type: OTHER; Name: oral hygiene; Assigned to Arm(s): 2 | Intervention Type: OTHER; Name: placebo; Assigned to Arm(s): 1
D: Arm Label: Raspall; Type: EXPERIMENTAL; Interventions: Procedure: Toothbrushing | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Toothbrushing; Assigned to Arm(s): Raspall

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Controlled Clinical Trial of Two Different Oral Care Regimens Combined With Ventilator-Associated Pneumonia (VAP) Bundle Strategy for Reduction of Duration of Mechanical Ventilation in a Neonatal Population
Brief Summary: The goal of this pilot study is to test the hypothesis that mechanically ventilated infants receiving Biotene OralBalance® gel for oral care would have a reduced intubation time compared to infants receiving oral care placebo. This study is also performed to test the feasibility as well the safety of Biotene OralBalance® gel.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Chlorhexidine gel | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo gel | Intervention Type: DRUG; Name: Chlorhexidine gel; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo gel; Assigned to Arm(s): 2
B: Arm Label: Pre-intubation CHX; Type: EXPERIMENTAL; Interventions: Procedure: Pre-intubation CHX | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Control | Intervention Type: PROCEDURE; Name: Pre-intubation CHX; Assigned to Arm(s): Pre-intubation CHX | Intervention Type: PROCEDURE; Name: Control; Assigned to Arm(s): Control
C: Arm Label: Biotene OralBalance® gel Arm; Type: EXPERIMENTAL; Interventions: Drug: Biotene OralBalance® gel | Arm Label: Sterile Water Arm; Type: PLACEBO_COMPARATOR; Interventions: Other: Sterile Water moisten cotton tipped applicator | Intervention Type: DRUG; Name: Biotene OralBalance® gel; Assigned to Arm(s): Biotene OralBalance® gel Arm | Intervention Type: OTHER; Name: Sterile Water moisten cotton tipped applicator; Assigned to Arm(s): Sterile Water Arm
D: Arm Label: Raspall; Type: EXPERIMENTAL; Interventions: Procedure: Toothbrushing | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Toothbrushing; Assigned to Arm(s): Raspall

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Systemic Consequences and Comorbidities in Mild/Moderate COPD, Time for Action!
Brief Summary: The aim of this prospective case-control study is to investigate the prevalence, severity and incidence of systemic consequences in newly detected patients with mild and moderate Chronic obstructive pulmonary disease (COPD). Special attention will be paid to skeletal muscle dysfunction and physical inactivity as these factors are, together with smoking, potentially modifiable.


Options:
A: Arm Label: resistance training; Type: EXPERIMENTAL; Interventions: Other: Resistance training | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Resistance training; Assigned to Arm(s): resistance training
B: Arm Label: patients with COPD; Type: N/A; Interventions: N/A | Arm Label: smoking controls; Type: N/A; Interventions: N/A | Arm Label: non-smoking controls; Type: N/A; Interventions: N/A
C: Arm Label: Exercise training on land; Type: OTHER; Interventions: Other: Exercise training | Arm Label: Exercise training on water; Type: OTHER; Interventions: Other: Exercise training | Intervention Type: OTHER; Name: Exercise training; Assigned to Arm(s): Exercise training on land, Exercise training on water
D: Arm Label: Acupuncture; Type: EXPERIMENTAL; Interventions: Other: Acupuncture, Other: Pulmonary Rehabilitation | Arm Label: Pulmonary Rehabilitation; Type: ACTIVE_COMPARATOR; Interventions: Other: Pulmonary Rehabilitation | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Acupuncture; Assigned to Arm(s): Acupuncture | Intervention Type: OTHER; Name: Pulmonary Rehabilitation; Assigned to Arm(s): Acupuncture | Intervention Type: OTHER; Name: Pulmonary Rehabilitation; Assigned to Arm(s): Pulmonary Rehabilitation

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: ADMINISTRATION OF NIFIDEPINE VERSUS ATOSIBAN IN PREGNANT WOMEN WITH A THREAT OF PREMATURE LABOR
Brief Summary: This is a study for pregnant women who have been diagnosed with Threatened Preterm Labor. The principal aim of this study is to compare the efficacy and safety of Nifedipine treatment versus Atosiban treatment over these patients' newborn babies.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Nifedlipine | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Magnesium | Intervention Type: DRUG; Name: Magnesium; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Nifedlipine; Assigned to Arm(s): 1
B: Arm Label: Active; Type: EXPERIMENTAL; Interventions: Drug: OBE022, Drug: Atosiban | Arm Label: Placebo; Type: ACTIVE_COMPARATOR; Interventions: Drug: Placebos, Drug: Atosiban | Intervention Type: DRUG; Name: OBE022; Assigned to Arm(s): Active | Intervention Type: DRUG; Name: Placebos; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Atosiban; Assigned to Arm(s): Active, Placebo
C: Arm Label: Nifedipine; Type: EXPERIMENTAL; Interventions: Drug: Nifedipine | Arm Label: Atosiban; Type: ACTIVE_COMPARATOR; Interventions: Drug: Atosiban | Intervention Type: DRUG; Name: Nifedipine; Assigned to Arm(s): Nifedipine | Intervention Type: DRUG; Name: Atosiban; Assigned to Arm(s): Atosiban
D: Arm Label: Indomethacin group; Type: EXPERIMENTAL; Interventions: Drug: Indomethacin | Arm Label: Nifedipine group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nifedipine | Intervention Type: DRUG; Name: Indomethacin; Assigned to Arm(s): Indomethacin group | Intervention Type: DRUG; Name: Nifedipine; Assigned to Arm(s): Nifedipine group

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Alzheimer's Disease Multiple Intervention Trial
Brief Summary: The purpose of this study is to conduct a two-year randomized, controlled clinical trial to improve functioning among older adults with Alzheimer's disease by comparing a control group receiving best practices primary care with an intervention group receiving best practice primary care plus a home-based occupational therapy intervention.


Options:
A: Intervention Type: BEHAVIORAL; Name: community occupational therapy in dementia; Assigned to Arm(s): N/A
B: Arm Label: Best practices primary care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Best practices primary care | Arm Label: Home based occupational therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Home based occupational therapy | Intervention Type: BEHAVIORAL; Name: Home based occupational therapy; Assigned to Arm(s): Home based occupational therapy | Intervention Type: BEHAVIORAL; Name: Best practices primary care; Assigned to Arm(s): Best practices primary care
C: Arm Label: Home Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Home based, flexible, stepped care intervention | Arm Label: Wait-list; Type: OTHER; Interventions: Behavioral: Home based, flexible, stepped care intervention after 6 months. Families will be free to choose any health care they desire during the waiting period. | Intervention Type: BEHAVIORAL; Name: Home based, flexible, stepped care intervention; Assigned to Arm(s): Home Care | Intervention Type: BEHAVIORAL; Name: Home based, flexible, stepped care intervention after 6 months. Families will be free to choose any health care they desire during the waiting period.; Assigned to Arm(s): Wait-list
D: Intervention Type: BEHAVIORAL; Name: care management; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Alzheimer's Disease Multiple Intervention Trial
Brief Summary: The purpose of this study is to conduct a two-year randomized, controlled clinical trial to improve functioning among older adults with Alzheimer's disease by comparing a control group receiving best practices primary care with an intervention group receiving best practice primary care plus a home-based occupational therapy intervention.


Options:
A: Arm Label: active tDCS plus real CT; Type: EXPERIMENTAL; Interventions: Device: active tDCS, Behavioral: real CT | Arm Label: sham tDCS plus real CT; Type: EXPERIMENTAL; Interventions: Device: sham tDCS, Behavioral: real CT | Arm Label: active tDCS plus placebo CT; Type: EXPERIMENTAL; Interventions: Device: active tDCS, Behavioral: placebo CT | Arm Label: sham tDCS plus placebo CT; Type: PLACEBO_COMPARATOR; Interventions: Device: sham tDCS, Behavioral: placebo CT | Intervention Type: DEVICE; Name: active tDCS; Assigned to Arm(s): active tDCS plus placebo CT, active tDCS plus real CT | Intervention Type: DEVICE; Name: sham tDCS; Assigned to Arm(s): sham tDCS plus placebo CT, sham tDCS plus real CT | Intervention Type: BEHAVIORAL; Name: real CT; Assigned to Arm(s): active tDCS plus real CT, sham tDCS plus real CT | Intervention Type: BEHAVIORAL; Name: placebo CT; Assigned to Arm(s): active tDCS plus placebo CT, sham tDCS plus placebo CT
B: Intervention Type: BEHAVIORAL; Name: In-home intervention; Assigned to Arm(s): N/A
C: Arm Label: usual care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: COPE plus usual care; Type: EXPERIMENTAL; Interventions: Behavioral: Care of Persons with Dementia in their Environments | Intervention Type: BEHAVIORAL; Name: Care of Persons with Dementia in their Environments; Assigned to Arm(s): COPE plus usual care
D: Arm Label: Best practices primary care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Best practices primary care | Arm Label: Home based occupational therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Home based occupational therapy | Intervention Type: BEHAVIORAL; Name: Home based occupational therapy; Assigned to Arm(s): Home based occupational therapy | Intervention Type: BEHAVIORAL; Name: Best practices primary care; Assigned to Arm(s): Best practices primary care

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Alzheimer's Disease Multiple Intervention Trial
Brief Summary: The purpose of this study is to conduct a two-year randomized, controlled clinical trial to improve functioning among older adults with Alzheimer's disease by comparing a control group receiving best practices primary care with an intervention group receiving best practice primary care plus a home-based occupational therapy intervention.


Options:
A: Arm Label: Integrated Chronic Kidney Disease care; Type: EXPERIMENTAL; Interventions: Behavioral: Integrated Chronic Kidney Disease care | Arm Label: Conventional CKD care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Conventional CKD care | Intervention Type: BEHAVIORAL; Name: Integrated Chronic Kidney Disease care; Assigned to Arm(s): Integrated Chronic Kidney Disease care | Intervention Type: BEHAVIORAL; Name: Conventional CKD care; Assigned to Arm(s): Conventional CKD care
B: Intervention Type: BEHAVIORAL; Name: care management; Assigned to Arm(s): N/A
C: Arm Label: Depression CAREPATH; Type: EXPERIMENTAL; Interventions: Other: Depression CAREPATH | Arm Label: Usual Care; Type: OTHER; Interventions: Other: Usual Care | Intervention Type: OTHER; Name: Depression CAREPATH; Assigned to Arm(s): Depression CAREPATH | Intervention Type: OTHER; Name: Usual Care; Assigned to Arm(s): Usual Care
D: Arm Label: Best practices primary care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Best practices primary care | Arm Label: Home based occupational therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Home based occupational therapy | Intervention Type: BEHAVIORAL; Name: Home based occupational therapy; Assigned to Arm(s): Home based occupational therapy | Intervention Type: BEHAVIORAL; Name: Best practices primary care; Assigned to Arm(s): Best practices primary care

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A 26-week Treatment, Multi-center, Randomized, Doubleblind, Double Dummy, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of QVA149 Compared to Fluticasone/Salmeterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Brief Summary: The purpose of this study is to compare the efficacy and safety/tolerability of indacaterol and glycopyrronium (QVA149) (fixed-dose combination) with fluticasone/salmeterol over a 26-week period in patients with moderate to severe COPD.


Options:
A: Arm Label: NVA237 dose 1; Type: EXPERIMENTAL; Interventions: Drug: NVA237 | Arm Label: Long-acting beta 2-agonist (LABA); Type: ACTIVE_COMPARATOR; Interventions: Drug: Long-acting beta 2-agonist (LABA), Drug: Placebo | Intervention Type: DRUG; Name: NVA237; Assigned to Arm(s): NVA237 dose 1 | Intervention Type: DRUG; Name: Long-acting beta 2-agonist (LABA); Assigned to Arm(s): Long-acting beta 2-agonist (LABA) | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Long-acting beta 2-agonist (LABA)
B: Arm Label: QVA149; Type: EXPERIMENTAL; Interventions: Drug: indacaterol and glycopyrronium (QVA149), Drug: Placebo to fluticasone/salmeterol | Arm Label: fluticasone/salmeterol; Type: ACTIVE_COMPARATOR; Interventions: Drug: fluticasone/salmeterol, Drug: Placebo to indacaterol and glycopyrronium (QVA149) | Intervention Type: DRUG; Name: indacaterol and glycopyrronium (QVA149); Assigned to Arm(s): QVA149 | Intervention Type: DRUG; Name: Placebo to fluticasone/salmeterol; Assigned to Arm(s): QVA149 | Intervention Type: DRUG; Name: fluticasone/salmeterol; Assigned to Arm(s): fluticasone/salmeterol | Intervention Type: DRUG; Name: Placebo to indacaterol and glycopyrronium (QVA149); Assigned to Arm(s): fluticasone/salmeterol
C: Arm Label: GFF MDI (PT003); Type: EXPERIMENTAL; Interventions: Drug: GFF MDI (PT 003) | Arm Label: GP MDI (PT001); Type: EXPERIMENTAL; Interventions: Drug: GP MDI (PT001) | Arm Label: FF MDI (PT005); Type: EXPERIMENTAL; Interventions: Drug: FF MDI (PT005) | Arm Label: Open-label tiotropium bromide inhalation powder; Type: ACTIVE_COMPARATOR; Interventions: Drug: Open-label tiotropium bromide inhalation (Spiriva® Handihaler®) | Intervention Type: DRUG; Name: GFF MDI (PT 003); Assigned to Arm(s): GFF MDI (PT003) | Intervention Type: DRUG; Name: GP MDI (PT001); Assigned to Arm(s): GP MDI (PT001) | Intervention Type: DRUG; Name: FF MDI (PT005); Assigned to Arm(s): FF MDI (PT005) | Intervention Type: DRUG; Name: Open-label tiotropium bromide inhalation (Spiriva® Handihaler®); Assigned to Arm(s): Open-label tiotropium bromide inhalation powder
D: Intervention Type: DRUG; Name: Salmeterol 50mcg/ Fluticasone Propionate 500mcg; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Contrast Enhanced Harmonic Endoscopic Ultrasound (CEH-EUS) Used in the Differentiation of Focal Pancreatic Masses
Brief Summary: The aim of the study is to assess the accuracy of real-time perfusion imaging pattern of pancreatic focal lesions visualized by contrast-enhanced harmonic endoscopic ultrasound (CEH-EUS) for the differential diagnosis between chronic pseudotumoral pancreatitis and pancreatic cancer in a prospective multicenter design.

The study will include patients with focal pancreatic masses evaluated by CEH-EUS and EUS-FNA. The diagnosis is usually unknown in the moment of the initial evaluation, the patients being included based on a suspicion of focal pancreatic masses after transabdominal ultrasound, CT or MR examinations. However, after a complete evaluation, a final diagnosis will be reached based on the combination of EUS-FNA cytology/pathology, surgical pathology and minimum 12 months follow-up.


Options:
A: Arm Label: Pancreatic adenocarcinoma; Type: N/A; Interventions: N/A | Arm Label: Chronic pancreatitis; Type: N/A; Interventions: N/A
B: Arm Label: 1.EUS-FNA with or without suction; Type: EXPERIMENTAL; Interventions: Procedure: 1.EUS-FNA with or without suction | Arm Label: 2.Pushing the stylet or injecting air; Type: EXPERIMENTAL; Interventions: Procedure: 2.Pushing the stylet or injecting air | Intervention Type: PROCEDURE; Name: 1.EUS-FNA with or without suction; Assigned to Arm(s): 1.EUS-FNA with or without suction | Intervention Type: PROCEDURE; Name: 2.Pushing the stylet or injecting air; Assigned to Arm(s): 2.Pushing the stylet or injecting air
C: Arm Label: Pancreatic adenocarcinoma; Type: N/A; Interventions: N/A | Arm Label: Chronic pancreatitis; Type: N/A; Interventions: N/A
D: Arm Label: 22G ProCore biopsy needle; Type: ACTIVE_COMPARATOR; Interventions: Procedure: 22G ProCore biopsy needle | Arm Label: 22G standard FNA needle; Type: ACTIVE_COMPARATOR; Interventions: Procedure: 22G standard FNA needle | Intervention Type: PROCEDURE; Name: 22G ProCore biopsy needle; Assigned to Arm(s): 22G ProCore biopsy needle | Intervention Type: PROCEDURE; Name: 22G standard FNA needle; Assigned to Arm(s): 22G standard FNA needle

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Motion Style Acupuncture Treatment for Low Back Pain With Severe Disability: a Randomised, Controlled, Trial Protocol
Brief Summary: Motion style acupuncture treatment(MSAT) is a treatment method in which the patient is exposed to active or passive movement and exercise during acupuncture, as opposed to conventional acupuncture. The purpose of this study is to investigate the effect of MSAT in the treating pain and severe functional disability in acute LBP patients.


Options:
A: Arm Label: acupuncture; Type: EXPERIMENTAL; Interventions: Other: acupuncture, injection | Arm Label: injections of diclofenac; Type: ACTIVE_COMPARATOR; Interventions: Other: acupuncture, injection | Intervention Type: OTHER; Name: acupuncture, injection; Assigned to Arm(s): acupuncture, injections of diclofenac
B: Arm Label: Opioid; Type: ACTIVE_COMPARATOR; Interventions: Drug: Naproxen, Drug: Oxycodone/ acetaminophen | Arm Label: Skeletal muscle relaxant; Type: ACTIVE_COMPARATOR; Interventions: Drug: Naproxen, Drug: Cyclobenzaprine | Arm Label: Naproxen alone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Naproxen | Intervention Type: DRUG; Name: Naproxen; Assigned to Arm(s): Naproxen alone, Opioid, Skeletal muscle relaxant | Intervention Type: DRUG; Name: Cyclobenzaprine; Assigned to Arm(s): Skeletal muscle relaxant | Intervention Type: DRUG; Name: Oxycodone/ acetaminophen; Assigned to Arm(s): Opioid
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Naproxen, Drug: Placebo | Arm Label: Orphenadrine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Orphenadrine, Drug: Naproxen | Arm Label: Methocarbamol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Methocarbamol, Drug: Naproxen | Intervention Type: DRUG; Name: Orphenadrine; Assigned to Arm(s): Orphenadrine | Intervention Type: DRUG; Name: Methocarbamol; Assigned to Arm(s): Methocarbamol | Intervention Type: DRUG; Name: Naproxen; Assigned to Arm(s): Methocarbamol, Orphenadrine, Placebo | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: ibuprofen + caffeine; Type: EXPERIMENTAL; Interventions: Drug: ibuprofen, Drug: caffeine | Arm Label: ibuprofen; Type: ACTIVE_COMPARATOR; Interventions: Drug: ibuprofen | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: ibuprofen; Assigned to Arm(s): ibuprofen, ibuprofen + caffeine | Intervention Type: DRUG; Name: caffeine; Assigned to Arm(s): ibuprofen + caffeine | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Motion Style Acupuncture Treatment for Low Back Pain With Severe Disability: a Randomised, Controlled, Trial Protocol
Brief Summary: Motion style acupuncture treatment(MSAT) is a treatment method in which the patient is exposed to active or passive movement and exercise during acupuncture, as opposed to conventional acupuncture. The purpose of this study is to investigate the effect of MSAT in the treating pain and severe functional disability in acute LBP patients.


Options:
A: Arm Label: group 1; Type: EXPERIMENTAL; Interventions: Other: acupuncture | Arm Label: group 2; Type: EXPERIMENTAL; Interventions: Other: acupuncture | Arm Label: group 3; Type: EXPERIMENTAL; Interventions: Other: acupuncture | Arm Label: group 4; Type: EXPERIMENTAL; Interventions: Other: acupuncture | Arm Label: group 5; Type: SHAM_COMPARATOR; Interventions: Other: acupuncture | Arm Label: group 6; Type: ACTIVE_COMPARATOR; Interventions: Drug: Itopride | Intervention Type: OTHER; Name: acupuncture; Assigned to Arm(s): group 1, group 2, group 3, group 4, group 5 | Intervention Type: DRUG; Name: Itopride; Assigned to Arm(s): group 6
B: Arm Label: group 1; Type: EXPERIMENTAL; Interventions: Other: acupuncture | Arm Label: Group 2; Type: EXPERIMENTAL; Interventions: Other: acupuncture | Arm Label: group 3; Type: EXPERIMENTAL; Interventions: Other: acupuncture | Arm Label: group 4; Type: SHAM_COMPARATOR; Interventions: Other: acupuncture | Intervention Type: OTHER; Name: acupuncture; Assigned to Arm(s): Group 2, group 1, group 3, group 4
C: Arm Label: acupuncture; Type: EXPERIMENTAL; Interventions: Other: acupuncture, injection | Arm Label: injections of diclofenac; Type: ACTIVE_COMPARATOR; Interventions: Other: acupuncture, injection | Intervention Type: OTHER; Name: acupuncture, injection; Assigned to Arm(s): acupuncture, injections of diclofenac
D: Arm Label: 1; Type: SHAM_COMPARATOR; Interventions: Device: Acupuncture | Intervention Type: DEVICE; Name: Acupuncture; Assigned to Arm(s): 1

Answer: C